2,3-dinor Thromboxane B1 (2,3-dinor TXB1) is primarily used as a biomarker in medical and clinical research to assess platelet activity and thromboxane production in the body. It is often measured in urine samples to evaluate the effectiveness of antiplatelet therapies, such as aspirin, in patients with cardiovascular diseases. By monitoring its levels, researchers and clinicians can gain insights into the risk of thrombotic events, such as heart attacks or strokes, and adjust treatment protocols accordingly. Additionally, it helps in studying the role of thromboxane in inflammatory processes and other conditions where platelet activation is a key factor.